UK Regulator Recalls Eye Drops Over Incorrect Expiry Dates

The MHRA has issued a Class 3 recall for specific batches of Aspire Pharma Limited's Tropicamide 1% Eye Drops. The recall is due to incorrect expiry dates printed on the packaging, with the actual expiry being October 31, 2026. Healthcare professionals must quarantine stock, but patients can continue use and contact pharmacists with concerns, minimizing immediate patient risk.